One of the most common reasons for a lack of response to ESA treatment is iron deficiency.,One common reasons lack response ESA treatment iron deficiency.,C0205447|C0205214|C0392360|C0332268|C0871261|C3890206|C0039798|C0302583|C0011155
"Within the family of barbiturates the oxibarbiturates and thiobarbiturates stand out, their primary representatives being pentobarbital and thiopental.","Within family barbiturates oxibarbiturates thiobarbiturates stand out, primary representatives pentobarbital thiopental.",G0000000|C0015576|C0004745|G0000000|C0039880|C0596013|C0439787|C0205225|C1882932|C0030883|C0039925
"We also included in the model the minimum daily MAP during barbiturate treatment, given that in the second and third days of treatment there were statistically significant differences between the groups in the univariate analysis.","We included model minimum daily MAP barbiturate treatment, days treatment statistically differences univariate analysis.",G0000000|C0332257|C3161035|C1524031|C0332173|C0024779|C0004745|C0039798|C0439228|C0039798|C0038215|C1705241|G0000000|C0002778
"Patients returned at 1, 2, 6, and 10 weeks after the quit day, with a final visit at 6 months.","Patients returned 1, 2, 6, 10 weeks quit day, final visit 6 months.",C0030705|C0332156|G0000000|G0000000|G0000000|C0450371|C0439230|C0748223|C0332173|C0205088|C0545082|G0000000|C0439231
This approach can be considered conventional treatment and is included in the BTF Guidelines as first-tier therapy [7].,This approach considered conventional treatment included BTF Guidelines first-tier therapy [7].,G0000000|C0449445|C0750591|C0439858|C0039798|C0332257|C1424602|C0162791|C0205435|C0039798|G0000000
"At the screening visit, all eligible patients received Pathways to Freedom: Winning the Fight Against Tobacco,22 a culturally sensitive smoking cessation guide that is written at the sixth grade reading level.","At screening visit, eligible patients received Pathways Freedom: Winning Fight Against Tobacco,22 culturally sensitive smoking cessation guide written sixth grade reading level.",G0000000|C0220908|C0545082|C1548635|C0030705|C1514756|C1704259|C0016694|C3538717|C0424324|G0000000|C0040329|C0010453|C0020517|C0037369|C1880019|C0181090|C0043266|C0205440|C0441800|C0034754|C0441889
"Compliance rates for return visits were 83%, 78%, 55%, and 52%, at 1, 2, 6, and 10 weeks, respectively.","Compliance rates return visits 83%, 78%, 55%, 52%, 1, 2, 6, 10 weeks, respectively.",C0009563|C0871208|C0332156|C0545082|C0450371|C0450371|C0450371|C0450371|G0000000|G0000000|G0000000|C0450371|C0439230|G0000000
"The objectives of the present study were to assess the effectiveness of pentobarbital and thiopental in terms of controlling refractory intracranial hypertension in patients with severe traumatic brain injury, and to evaluate the adverse effects of treatment.","The objectives study assess effectiveness pentobarbital thiopental terms controlling refractory intracranial hypertension patients severe traumatic brain injury, evaluate adverse effects treatment.",G0000000|C0018017|C0557651|C1516048|C1280519|C0030883|C0039925|C0233324|C2239193|C0205269|C0524466|C0020538|C0030705|C0205082|C0332663|C0006104|C3263722|C0220825|G0000000|C1280500|C0039798
"At the experimental level, research has demonstrated that mechanisms of action and levels of neuroprotection differ between these agents [3-6].","At experimental level, demonstrated mechanisms action levels neuroprotection agents [3-6].",G0000000|C1517586|C0441889|G0000000|C0441712|C0441472|C0441889|C0598958|C0450442|G0000000
"Mean Hb week by week for intravenous (IV) iron, oral iron, and oral placebo cohorts.","Mean Hb week week intravenous (IV) iron, oral iron, oral placebo cohorts.",C0444504|C0019046|C0332174|C0332174|C0348016|C0022326|C0302583|C0442027|C0302583|C0442027|C0032042|C0599755
"All patients' ICP was monitored using an intraparenchymal Camino catheter (Integra Neurosciences, Plainsboro, NJ, USA).","All patients' ICP monitored intraparenchymal Camino catheter (Integra Neurosciences, Plainsboro, NJ, USA).",G0000000|C0030705|C1881201|C0030695|C3898701|G0000000|C0085590|G0000000|C0027910|G0000000|C0027971|C0041703
No psychological counseling was done.,No psychological counseling done.,G0000000|C0205486|C0010210|G0000000
There were no significant differences between the two groups with respect to the incidence of arterial hypotension or infection.,There differences respect incidence arterial hypotension infection.,G0000000|C1705241|C0679133|C0021149|C0003842|C0020649|C0009450
The ICP catheter was placed in the frontal region of the hemisphere with more radiological lesions on the CT.,The ICP catheter frontal region hemisphere radiological lesions CT.,G0000000|C1881201|C0085590|C0205123|C0017446|C0205139|C0034599|C0221198|C0007673
"Efforts should be made to reach underserved populations through smoking cessation programs, and to assist in maintaining abstinence.","Efforts reach underserved populations smoking cessation programs, assist maintaining abstinence.",C0015264|C2584321|G0000000|C0032659|C0037369|C1880019|C0376691|C0018896|C0024501|C3843422
"From May 2002 to July 2007, 480 TBI patients were admitted to the intensive care unit of the Son Dureta University Hospital.","From May 2002 July 2007, 480 TBI patients admitted intensive care unit Son Dureta University Hospital.",G0000000|G0000000|G0000000|C3829447|G0000000|C1442061|C0876926|C0030705|C0184666|C0162425|C1947933|C0439148|C0037683|G0000000|C0041740|C0019994
We also recorded findings of CTs conducted before inclusion of the patients in the study.,We recorded findings CTs conducted inclusion patients study.,G0000000|C0034869|C2607943|C0007286|C0004927|C0007637|C0030705|C0557651
"(Trial registration: US Clinical Trials registry {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00622570"",""term_id"":""NCT00622570""}}NCT00622570.)","(Trial registration: US Clinical Trials registry {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00622570"",""term_id"":""NCT00622570""}}NCT00622570.)",C0008976|C1514821|G0000000|C0205210|C0008976|C0034975|C0332307
The summary of prognostic variables for the 44 patients is shown in Table Table2.2.,The summary prognostic variables 44 patients Table Table2.2.,G0000000|C1552616|C0220901|C0439828|C0450371|C0030705|C0039224|G0000000
Time to erythropoietic response and first RBC transfusion were summarized by using Kaplan-Meier methodology.,Time erythropoietic response RBC transfusion summarized Kaplan-Meier methodology.,C0040223|C0312829|C0871261|C0014792|C0005841|G0000000|G0000000|C0969625
"Nevertheless, its effect on outcome is unproven [2], mainly because of severe medical complications.","Nevertheless, outcome unproven [2], severe medical complications.",G0000000|C1274040|C0456370|G0000000|C0205082|C0199168|C0009566
"Electroencephalography was conducted daily in a noncontinuous manner (Nicolet; Viasys Healthcare, Verona Road, Madison, WI, USA).","Electroencephalography conducted daily noncontinuous manner (Nicolet; Viasys Healthcare, Verona Road, Madison, WI, USA).",C0013819|C0004927|C0332173|G0000000|G0000000|G0000000|G0000000|C0086388|G0000000|C0442650|G0000000|C0043193|C0041703
"These benefits have included higher rates of Hb response to ESAs, increased Hb increment from baseline levels, decreased ESA dose requirements, or improved QOL.","These benefits included rates Hb response ESAs, increased Hb increment baseline levels, decreased ESA dose requirements, improved QOL.",G0000000|C0814225|C0332257|C0871208|C0019046|C0871261|C3472649|C0205217|C0019046|C1705117|C0168634|C0441889|C0205216|C3890206|C0178602|C1514873|C0184511|C0518214
Patients who met eligibility criteria at the screening visit were scheduled 1 to 2 weeks later for their randomization visit.,Patients met eligibility criteria screening visit scheduled 1 2 weeks randomization visit.,C0030705|C0268621|C0013893|C0243161|C0220908|C0545082|C0086960|G0000000|G0000000|C0439230|C0034656|C0545082
"Darbepoetin was to be held for Hb greater than 13.0 g/dL, until Hb decreased to less than 12.0 g/dL; then darbepoetin was restarted with a 25% dose reduction.","Darbepoetin held Hb 13.0 g/dL, Hb decreased 12.0 g/dL; darbepoetin restarted 25% dose reduction.",G0000000|C0675390|C0019046|C0450371|C0439267|C0019046|C0205216|C0450371|C0439267|G0000000|C1514902|C0450371|C0178602|C0301630
"Although it was not a main objective of the study, patients were evaluated 6 months after injury using the Glasgow Outcome Scale [14].","Although main objective study, patients evaluated 6 months injury Glasgow Outcome Scale [14].",G0000000|C0205225|C0018017|C0557651|C0030705|C0220825|G0000000|C0439231|C3263722|G0000000|C1274040|C0175659|C0450371
These findings should be interpreted with caution because of the imbalance in cranial tomography characteristics and the different dosages employed in the two arms of the study.,These findings interpreted caution imbalance cranial tomography characteristics dosages employed arms study.,G0000000|C2607943|C1285553|G0000000|C1397014|C0037303|C0040395|C1521970|C0178602|C0014003|C0206655|C0557651
Preliminary results for the first 20 patients have already been published elsewhere [16].,Preliminary 20 patients published [16].,C0439611|C0450371|C0030705|C0034037|C0450371
"It is registered with the US Clinical Trials Registry, with the number {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00622570"",""term_id"":""NCT00622570""}}NCT00622570.","It registered US Clinical Trials Registry, {""type"":""clinical-trial"",""attrs"":{""text"":""NCT00622570"",""term_id"":""NCT00622570""}}NCT00622570.",G0000000|C1514821|G0000000|C0205210|C0008976|C0034975|C0332307
"Owing to the prevalence of low literacy among our patients,20 the consent form was read aloud, and the research assistants administered the survey instrument.","Owing prevalence low literacy patients,20 consent form read aloud, assistants administered survey instrument.",G0000000|C0033105|C0205251|C0023864|C0030705|C1511481|C0348078|C0034754|G0000000|C0011327|C1521801|C0038951|C0348000
CTs were independently reviewed and categorized by two neurosurgeons (JI and MB) who were unaware of the treatment group to which the patients had been assigned.,CTs independently reviewed categorized neurosurgeons (JI MB) unaware treatment patients assigned.,C0007286|G0000000|C0282443|C0871968|C0237427|G0000000|C0024853|C0150114|C0039798|C0030705|C1516050
"In the nephrology/hemodialysis setting, parenteral iron administration is a standard practice, but use of IV iron is currently infrequent in oncology clinics.","In nephrology/hemodialysis setting, parenteral iron administration standard practice, IV iron infrequent oncology clinics.",G0000000|C0027712|C0542559|C0030547|C0302583|C0001554|C1442989|C0237607|C0022326|C0302583|C0521114|C0027651|C0442592
Patient disposition is presented in Figure 1.,Patient disposition Figure 1.,C0030705|C0743223|G0000000|G0000000
"Independent-sample t test procedures were used, and a clinically significant result was defined as a shift of 10 points on a 0- to 100-point transformed scale between the average QOL scores of the two variants of iron therapy or oral placebo.","Independent-sample test procedures used, clinically result defined shift 10 0- 100-point transformed scale average QOL scores variants iron therapy oral placebo.",C0085862|C0022885|C0025664|C1273517|G0000000|C1274040|C1704788|C0333051|C0450371|G0000000|C1442061|C1510411|C0175659|C1510992|C0518214|C0449820|C0205419|C0302583|C0039798|C0442027|C0032042
"Patients were instructed to apply a new patch system each morning to a dry skin site on the upper torso, upper back, or upper, outer arm on a 7-day cycle.","Patients instructed apply patch system morning dry skin site upper torso, upper back, upper, outer arm 7-day cycle.",C0030705|G0000000|C1632850|C0332461|C0449913|C0332170|C0011682|C0444099|C0205145|C1282910|C0460005|C1282910|C0004600|C1282910|C0205101|C0446516|C0332173|C1511572
All women in the intervention group were re-invited for screening yearly unless they requested otherwise.,All women intervention re-invited screening yearly requested otherwise.,G0000000|C0043210|C0886296|C0556581|C0220908|C0332181|C1272683|G0000000
Comparison of the change in Hb levels from baseline to week 6 and week 15 between pairs of treatment arms was done via two-sample t tests (both for week 6 and week 15).,Comparison change Hb levels baseline week 6 week 15 pairs treatment arms two-sample tests (both week 6 week 15).,C1707455|C0392747|C0019046|C0441889|C0168634|C0332174|G0000000|C0332174|C0450371|C1709450|C0039798|C0206655|C0205448|C0022885|G0000000|C0332174|G0000000|C0332174|C0450371
"In those patients in whom barbiturate coma did not control ICP, we used decompressive craniotomy and/or external lumbar drainage, in accordance with the Munch criteria, as life-saving measures [11,12].","In patients barbiturate coma control ICP, decompressive craniotomy and/or external lumbar drainage, Munch criteria, life-saving measures [11,12].",G0000000|C0030705|C0004745|C0009421|C0243148|C1881201|C0011117|C0010280|G0000000|C0205101|C0024090|C0012621|G0000000|C0243161|C0376558|C0079809|C0450371
"At follow-up visits, after 1, 2, 6, and 10 weeks, patients were asked about adherence to use of the patch since their previous visit.","At follow-up visits, 1, 2, 6, 10 weeks, patients adherence patch previous visit.",G0000000|C0589120|C0545082|G0000000|G0000000|G0000000|C0450371|C0439230|C0030705|C1510802|C0332461|C0205156|C0545082
"For this reason, research is needed to compare the effectiveness of these two drugs in terms of controlling refractory ICH in patients with severe TBI.","For reason, compare effectiveness drugs terms controlling refractory ICH patients severe TBI.",G0000000|C0392360|C1707455|C1280519|C0013227|C0233324|C2239193|C0205269|C0019191|C0030705|C0205082|C0876926
Thiopental appeared to be more effective than pentobarbital in controlling intracranial hypertension refractory to first-tier measures.,Thiopental appeared effective pentobarbital controlling intracranial hypertension refractory first-tier measures.,C0039925|C0700364|C1280519|C0030883|C2239193|C0524466|C0020538|C0205269|C0205435|C0079809
"With 176 evaluable patients per treatment arm, there would have been ≥ 80% power to detect a difference across two treatment arms of 15% in the primary erythropoietic response end point through Fisher's exact test, if the true percentage of patients that experience a erythropoietic response was at least 30% in the superior group, with a 2.5% type I error rate.","With 176 evaluable patients treatment arm, ≥ 80% power detect difference treatment arms 15% primary erythropoietic response Fisher's exact test, true percentage patients experience erythropoietic response 30% superior group, 2.5% type I error rate.",G0000000|C1442061|C1516986|C0030705|C0039798|C0446516|G0000000|C0450371|C0032863|C0442726|C1705241|C0039798|C0206655|C0450371|C0205225|C0312829|C0871261|C0325045|C2828393|C0022885|C0205238|C0439165|C0030705|C0237607|C0312829|C0871261|C0450371|C1282910|C0441833|G0000000|C0332307|C0021966|C0743559|C0871208
"These are variables such as age, GCS score at admission, and the worst CT obtained within 24 hours before inclusion of the patient in the study, as well as the type of barbiturate administered.","These variables age, GCS score admission, worst CT 24 hours inclusion patient study, type barbiturate administered.",G0000000|C0439828|C0001779|G0000000|C0449820|C0184666|C1522166|C0007673|C0450371|C0439227|C0007637|C0030705|C0557651|C0332307|C0004745|C1521801
All patches were packaged in unlabeled boxes that held a 2-week supply.,All patches packaged unlabeled boxes held 2-week supply.,G0000000|C0994894|C0030176|G0000000|C0179400|C0675390|C0332174|C0243163
"The reasons for not including the remaining 27 refractory ICH cases were as follows: 13 patients were included in other studies, six were older than 76 years, five were admitted with nonreacting midriatic pupils and with clinical evidence of brain death, two presented with haemodynamic instability at the time of randomization, and one patient was transferred to a different hospital during the first 24 hours of admission, which excluded that patient from follow-up analysis.","The reasons including remaining 27 refractory ICH follows: 13 patients included studies, 76 years, admitted nonreacting midriatic pupils clinical evidence brain death, haemodynamic instability time randomization, patient transferred hospital 24 hours admission, excluded patient follow-up analysis.",G0000000|C0392360|C0332257|C1527428|C0450371|C0205269|C0019191|C0332283|C0450371|C0030705|C0332257|C0947630|C0450371|C0439234|C0184666|G0000000|G0000000|C0034121|C0205210|C3887511|C0006104|C0011065|C0019010|C1444783|C0040223|C0034656|C0030705|C0348011|C0019994|C0450371|C0439227|C0184666|C1554077|C0030705|C0589120|C0002778
"In cases of disagreement between these investigators, a third investigator reviewed the CT images.","In disagreement investigators, investigator reviewed CT images.",G0000000|C0680238|C0035173|C0035173|C0282443|C0007673|C1704254
"Before randomization of the patient to a study group, we required that patient to have received maximal medical treatment (first-level measures).","Before randomization patient study group, required patient received maximal medical treatment (first-level measures).",C0332152|C0034656|C0030705|C0557651|C0441833|C1514873|C0030705|C1514756|C0205289|C0199168|C0039798|C0563053|C0079809
Randomization was based on a computer-generated list that intercollated the two drugs.,Randomization based computer-generated list intercollated drugs.,C0034656|C1527178|C0009622|C0745732|G0000000|C0013227
"Allocation was done by the intensive care unit physician who was on duty, once the patient had been found to meet the inclusion criteria and none of the exclusion criteria.","Allocation intensive care unit physician duty, patient meet inclusion criteria exclusion criteria.",C1706778|C0162425|C1947933|C0439148|C0031831|G0000000|C0030705|C1550543|C0007637|C0243161|C0680251|C0243161
"Linear and quadratic changes of QOL were examined over time, and these time trends were compared among the three treatment assignments.","Linear quadratic QOL examined time, time trends compared treatment assignments.",C0205132|G0000000|C0518214|C0332128|C0040223|C0040223|C0040833|C1707455|C0039798|C1516050
"This study was conducted at Son Dureta University Hospital (Palma de Mallorca, Spain) and was approved by the Ethics Committee of the Balearic Islands on 31 March 2002.","This study conducted Son Dureta University Hospital (Palma de Mallorca, Spain) approved Ethics Committee Balearic Islands 31 March 2002.",G0000000|C0557651|C0004927|C0037683|G0000000|C0041740|C0019994|C0817662|C0011198|C0454825|C0037747|C0205540|C0015000|C2699414|G0000000|C0022130|C0450371|C3829202|G0000000
"Premedications before IV iron administration, including diphenhydramine, were permitted at the discretion of individual investigators.","Premedications IV iron administration, including diphenhydramine, permitted discretion individual investigators.",C0033045|C0022326|C0302583|C0001554|C0332257|C0012522|C0329040|G0000000|C0027361|C0035173
"This was a prospective, randomized, cohort study comparing two treatments: pentobarbital and thiopental.","This prospective, randomized, cohort study comparing treatments: pentobarbital thiopental.",G0000000|C0023981|C0034656|C0599755|C0557651|C1707455|C0087111|C0030883|C0039925
These rates are comparable to response rates observed in prior studies of ESA alone with similar eligibility and response criteria.2 Mean hemoglobin (Hb) over the course of the study.,These rates comparable response rates observed prior studies ESA eligibility response criteria.2 Mean hemoglobin (Hb) study.,G0000000|C0871208|G0000000|C0871261|C0871208|C1441672|C0332152|C0947630|C3890206|C0013893|C0871261|C0243161|C0444504|C0019046|C0019046|C0557651
The transdermal nicotine patch for 10 weeks as an adjunct to brief counseling.,The transdermal nicotine patch 10 weeks adjunct counseling.,G0000000|C0040652|C0028040|C0332461|C0450371|C0439230|G0000000|C0010210
Side effects and adverse effects of patch use were also recorded.,Side effects adverse effects patch recorded.,C0441987|C1280500|G0000000|C1280500|C0332461|C0034869
"The study plan was to enroll 194 patients per arm, with a 10% attrition rate assumed because of ineligibility, drop-outs, and losses to follow-up.","The study plan enroll 194 patients arm, 10% attrition rate assumed ineligibility, drop-outs, losses follow-up.",G0000000|C0557651|C0270724|G0000000|C1442061|C0030705|C0446516|C0450371|C0004277|C0871208|C3242379|C1512714|C1321095|C1517945|C0589120
All patients with severe TBI underwent cranial computed tomography (CT) upon admission and were categorized in accordance with the classification proposed by the Traumatic Coma Data Bank [8].,All patients severe TBI underwent cranial computed tomography (CT) admission categorized classification proposed Traumatic Coma Data Bank [8].,G0000000|C0030705|C0205082|C0876926|G0000000|C0037303|C1441526|C0040395|C0007673|C0184666|C0871968|C0008902|C1553874|C0332663|C0009421|C1511726|C0442598|G0000000
"To describe the ICP, we also followed the criteria previously employed by Stocchetti and coworkers [13]; the arithmetic mean of ICP data recorded during every 24-hour period, after filtering to exclude inaccurate readings, was calculated and expressed as 'mean ICP'.","To ICP, criteria employed Stocchetti coworkers [13]; arithmetic ICP data recorded 24-hour period, filtering exclude inaccurate readings, calculated expressed 'mean ICP'.",C0040363|C1881201|C0243161|C0014003|G0000000|C0681088|C0450371|C0871653|C1881201|C1511726|C0034869|C0450371|C0439531|C0180860|C0332196|C0443236|C0034754|C0444686|G0000000|C0444504|C1881201
"Both treatment groups were very similar in terms of other known prognostic variables, such as the presence of hypoxia, hypotension before hospital admission and pupil reactivity, and the univariate analysis did not identify differences between them, so these were not included in the multivariate analysis.","Both treatment terms prognostic variables, presence hypoxia, hypotension hospital admission pupil reactivity, univariate analysis identify differences them, included multivariate analysis.",G0000000|C0039798|C0233324|C0220901|C0439828|C0150312|C0242184|C0020649|C0019994|C0184666|C0034121|C0443286|G0000000|C0002778|G0000000|C1705241|G0000000|C0332257|G0000000|C0002778
Uncontrollable intracranial pressure occurred in 11 patients (50%) in the thiopental treatment group and in 18 patients (82%) in the pentobarbital group (P = 0.03).,Uncontrollable intracranial pressure occurred 11 patients (50%) thiopental treatment 18 patients (82%) pentobarbital (P = 0.03).,G0000000|C0524466|C0033095|C1709305|C0450371|C0030705|C0450371|C0039925|C0039798|C0450371|C0030705|C0450371|C0030883|C0369773|G0000000|C0450371
"Uncontrollable ICP was defined as follows: ICP of 21 to 35 mmHg for 4 hours, ICP of 36 to 40 mmHg for 1 hour, or ICP above 41 mmHg for 5 minutes, in the absence of external interventions.","Uncontrollable ICP defined follows: ICP 21 35 mmHg 4 hours, ICP 36 40 mmHg 1 hour, ICP 41 mmHg 5 minutes, absence external interventions.",G0000000|C1881201|C1704788|C0332283|C1881201|C0450371|C0450371|C0439475|G0000000|C0439227|C1881201|C0450371|C0450371|C0439475|G0000000|C0439227|C1881201|C0450371|C0439475|G0000000|C0439232|C0332197|C0205101|C0886296
"When ICP was controlled (<20 mmHg for 48 hours), we conducted a step-wise reduction in the barbiturate coma in steps that reduced the dosage by 50% every 24 hours until the infusion was suspended.","When ICP controlled (<20 mmHg 48 hours), conducted step-wise reduction barbiturate coma steps reduced dosage 50% 24 hours infusion suspended.",G0000000|C1881201|C2587213|C0450371|C0439475|C0450371|C0439227|C0004927|C1261552|C0301630|C0004745|C0009421|C1261552|C0392756|C0178602|C0450371|C0450371|C0439227|C0574032|C1553389
"For all comparisons, we considered statistical significance to have been achieved if the two-tailed α error probability was 5% or less (P ≤ 0.05).","For comparisons, considered statistical significance achieved two-tailed α error probability 5% (P ≤ 0.05).",G0000000|C1707455|C0750591|C0038215|C0237881|G0000000|C0205448|G0000000|C0743559|C0033204|G0000000|C0369773|G0000000|C0450371
"Patients with severe anemia at enrollment were more likely to require a transfusion than those with milder anemia (21% of patients [95% CI,14% to 29%] v 10% [95% CI of 7% to 14%]; P = .0031).","Patients severe anemia enrollment require transfusion milder anemia (21% patients [95% CI,14% 29%] 10% [95% CI 7% 14%]; P = .0031).",C0030705|C0205082|C0002871|C1516879|G0000000|C0005841|C2945599|C0002871|C0450371|C0030705|C0450371|C0008107|C0450371|C0450371|C0450371|C0008107|G0000000|C0450371|C0369773|G0000000|G0000000
"The study was approved by institutional review boards of participating institutions, and all participants provided written informed consent.","The study approved institutional review boards participating institutions, participants provided written informed consent.",G0000000|C0557651|C0205540|C0018704|C0282443|C0972401|C0679823|C1272753|C0679646|C1999230|C0043266|C1522154|C1511481
Outpatient in an inner-city hospital.,Outpatient inner-city hospital.,C0029921|C0557849|C0019994
"At randomization, patients were seen in groups of two to four.","At randomization, patients four.",G0000000|C0034656|C0030705|C0205450
P < .05 considered significant.,P < .05 considered significant.,C0369773|G0000000|C0450371|C0750591|C0237881
"In the event of ICP values rising to the study's inclusion values during the withdrawal of barbiturate treatment, the perfusion dosage was once again increased to achieve control of the patient's ICP.","In event ICP values rising study's inclusion values withdrawal barbiturate treatment, perfusion dosage increased achieve control patient's ICP.",G0000000|C0441471|C1881201|C0042295|G0000000|C0557651|C0007637|C0042295|C2349954|C0004745|C0039798|C0031001|C0178602|C0205217|G0000000|C0243148|C0030705|C1881201
Results According to Treatment Group NOTE.,Results According Treatment Group NOTE.,C1274040|C0680240|C0039798|C0441833|C1316572
Experimental research has demonstrated that the level of neuroprotection conferred by the various barbiturates is not equal.,Experimental demonstrated level neuroprotection conferred barbiturates equal.,C1517586|G0000000|C0441889|C0598958|G0000000|C0004745|C0205163
"Moreover, whites and African Americans have significantly different smoking behaviors, so that findings from previous smoking cessation studies may not be generalizable to African-American smokers.","Moreover, whites African Americans smoking behaviors, findings previous smoking cessation studies generalizable African-American smokers.",G0000000|C0007457|C0027567|C0596070|C0037369|C0004927|C2607943|C0205156|C0037369|C1880019|C0947630|G0000000|C0085756|C0337664
"For the comparison of qualitative variables, we used χ2 or Fisher's exact test, as appropriate.","For comparison qualitative variables, χ2 Fisher's exact test, appropriate.",G0000000|C1707455|C0205556|C0439828|G0000000|C0325045|C2828393|C0022885|C1548787
As in Table Table11 the characteristics of the worst CT conducted before inclusion in the study differed between the two groups.,As Table Table11 characteristics worst CT conducted inclusion study differed groups.,G0000000|C0039224|G0000000|C1521970|C1522166|C0007673|C0004927|C0007637|C0557651|G0000000|C0441833
"In support of our work in the present study, the BTF Guidelines recommend that studies be undertaken to compare the effectiveness of the different barbiturates that are currently used in TBI patients [1].","In support study, BTF Guidelines recommend studies undertaken compare effectiveness barbiturates TBI patients [1].",G0000000|C0183683|C0557651|C1424602|C0162791|C0034866|C0947630|G0000000|C1707455|C1280519|C0004745|C0876926|C0030705|G0000000
"On average, the barbiturate coma was initiated in the thiopental group at 89 ± 15.5 hours after admission and in the pentobarbital group at 61 ± 14.3 hours after admission (P = 0.33).","On average, barbiturate coma initiated thiopental 89 ± 15.5 hours admission pentobarbital 61 ± 14.3 hours admission (P = 0.33).",G0000000|C1510992|C0004745|C0009421|C1548602|C0039925|C0450371|G0000000|C0450371|C0439227|C0184666|C0030883|C0450371|G0000000|C0450371|C0439227|C0184666|C0369773|G0000000|C0450371
"The baseline characteristics of the 44 patients included in the study, 22 randomized to each group, are presented in Table Table1.1.","The baseline characteristics 44 patients included study, 22 randomized group, Table Table1.1.",G0000000|C0168634|C1521970|C0450371|C0030705|C0332257|C0557651|C0450371|C0034656|C0441833|C0039224|G0000000
"Baseline characteristics of patient population Age, ISS, SAPS II, APACHE II and APACHE III are expressed as median and interquartile range.","Baseline characteristics patient population Age, ISS, SAPS II, APACHE II APACHE III expressed median interquartile range.",C0168634|C1521970|C0030705|C0032659|C0001779|C1845118|C1705598|G0000000|C0243030|G0000000|C0243030|C0439070|G0000000|C0549183|G0000000|C1514721
"The total number of units of blood transfused and the proportion of patients requiring transfusion were similar between arms (Table 2), both during the whole 16-week study and when only patients transfused after week 5 were considered.","The total units blood transfused proportion patients requiring transfusion arms (Table 2), 16-week study patients transfused week 5 considered.",G0000000|C0439175|C0439148|C0005767|C1549003|C1709707|C0030705|G0000000|C0005841|C0206655|C0039224|G0000000|C0450371|C0557651|C0030705|C1549003|C0332174|G0000000|C0750591
Results were analyzed by an experienced neurologist who was blinded to the treatment of the patients.,Results analyzed experienced neurologist blinded treatment patients.,C1274040|C0936012|C0237607|C0237426|C0150108|C0039798|C0030705
Pretreatment ferritin and C-reactive protein levels did not differ between responders and nonresponders.,Pretreatment ferritin C-reactive protein levels responders nonresponders.,C1550147|C0015879|C0205332|C0033684|C0441889|G0000000|G0000000
Patients were randomized to one of two study arms based on a computer-generated random numbers table with a block size set at 20.,Patients randomized study arms based computer-generated random table block size set 20.,C0030705|C0034656|C0557651|C0206655|C1527178|C0009622|C0034656|C0039224|C0028778|C0456389|C0036849|C0450371
Prognostic variables of patient population Admission GCS is expressed as median (interquartile range).,Prognostic variables patient population Admission GCS expressed median (interquartile range).,C0220901|C0439828|C0030705|C0032659|C0184666|G0000000|G0000000|C0549183|G0000000|C1514721
The manual has three parts: a presentation of the characteristics of cigarette smoking among African Americans; instructions on how to quit smoking; and suggestions for how communities can combat tobacco dependence by working collaboratively.,The manual parts: presentation characteristics cigarette smoking African Americans; instructions quit smoking; suggestions communities combat tobacco dependence collaboratively.,G0000000|C0024763|C0449719|C0449450|C1521970|C0677453|C0037369|C0027567|C0596070|C0302828|C0748223|C0037369|C0038659|C0009462|G0000000|C0040329|C0011546|G0000000
"At the 2-week follow-up visit, they received 2 weeks each of 14 mg/d and 7 mg/d.","At 2-week follow-up visit, received 2 weeks 14 mg/d 7 mg/d.",G0000000|C0332174|C0589120|C0545082|C1514756|G0000000|C0439230|C0450371|C0439422|G0000000|C0439422
The incidence of adverse effects was similar in both groups.,The incidence adverse effects groups.,G0000000|C0021149|G0000000|C1280500|C0441833
"Planned enrollment was 582 patients, but the study met an early stopping rule because of an excess of serious AEs in the IV iron arm.","Planned enrollment 582 patients, study met stopping rule excess AEs IV iron arm.",C1301732|C1516879|C1442061|C0030705|C0557651|C0268621|C0723457|C0805874|C1979886|C1412268|C0022326|C0302583|C0446516
Chemotherapy-associated anemia (CAA) is a common problem for patients with cancer and is associated with requirement for RBC transfusions and with decreased quality of life (QOL).,Chemotherapy-associated anemia (CAA) common patients cancer requirement RBC transfusions decreased quality life (QOL).,C0013216|C0002871|G0000000|C0205214|C0030705|C0006826|C1514873|C0014792|C0005841|C0205216|C0332306|C0376558|C0518214
"Of these 480 patients, 71 (14.8%) presented with ICH refractory to first-level measures, of whom 44 were included in the study.","Of 480 patients, 71 (14.8%) ICH refractory first-level measures, 44 included study.",G0000000|C1442061|C0030705|C0450371|C0450371|C0019191|C0205269|C0563053|C0079809|C0450371|C0332257|C0557651
"There was no difference in the erythropoietic response rate (ie, proportion of patients achieving Hb ≥12 g/dL or Hb increase ≥ 2 g/dL from baseline): 69.5% (95% CI, 61.9% to 76.5%) of IV iron-treated patients achieved an erythropoietic response compared with 66.9% (95% CI, 59.1% to 74.0%) who received oral iron and 65.0% (95% CI, 57.2% to 72.3%) who received oral placebo (P = .75).","There difference erythropoietic response rate (ie, proportion patients achieving Hb ≥12 g/dL Hb increase ≥ 2 g/dL baseline): 69.5% (95% CI, 61.9% 76.5%) IV iron-treated patients achieved erythropoietic response compared 66.9% (95% CI, 59.1% 74.0%) received oral iron 65.0% (95% CI, 57.2% 72.3%) received oral placebo (P = .75).",G0000000|C1705241|C0312829|C0871261|C0871208|G0000000|C1709707|C0030705|G0000000|C0019046|G0000000|C0439267|C0019046|C0442805|G0000000|G0000000|C0439267|C0168634|C0450371|C0450371|C0008107|C0450371|C0450371|C0022326|C0302583|C0030705|G0000000|C0312829|C0871261|C1707455|C0450371|C0450371|C0008107|C0450371|C0450371|C1514756|C0442027|C0302583|C0450371|C0450371|C0008107|C0450371|C0450371|C1514756|C0442027|C0032042|C0369773|G0000000|C0450371
"Until now no controlled studies have been conducted to compare their effectiveness, even though the Brain Trauma Foundation Guidelines recommend that such studies be undertaken.","Until controlled studies conducted compare effectiveness, Brain Trauma Foundation Guidelines recommend studies undertaken.",G0000000|C2587213|C0947630|C0004927|C1707455|C1280519|C0006104|C0043251|C0016617|C0162791|C0034866|C0947630|G0000000
"The three doses of transdermal nicotine patches provide an average steady-state plasma nicotine concentration of 17, 12, and 6 ng/mL, respectively.21 Placebo systems contained a pharmacologically irrelevant amount of nicotine in the drug reservoir to mimic the odor of active systems but delivered less than 1 mg of nicotine in 24 hours.","The doses transdermal nicotine patches provide average steady-state plasma nicotine concentration 17, 12, 6 ng/mL, respectively.21 Placebo systems contained pharmacologically irrelevant amount nicotine drug reservoir mimic odor active systems delivered 1 nicotine 24 hours.",G0000000|C0178602|C0040652|C0028040|C0994894|C1999230|C1510992|C0678587|C0032105|C0028040|C0004268|C0450371|C0450371|G0000000|C0439275|C0450371|C0032042|C0449913|C0332256|G0000000|G0000000|C1265611|C0028040|C0013227|C0442537|G0000000|C0028884|C0205177|C0449913|C1705822|G0000000|C0028040|C0450371|C0439227
Our primary objective was to compare the effectiveness of these agents in controlling refractory ICH in patients with severe TBI.,Our primary objective compare effectiveness agents controlling refractory ICH patients severe TBI.,G0000000|C0205225|C0018017|C1707455|C1280519|C0450442|C2239193|C0205269|C0019191|C0030705|C0205082|C0876926
bMiotic pupils were considered as reactive.,bMiotic pupils considered reactive.,G0000000|C0034121|C0750591|C0205332
This study investigated whether response to darbepoetin alfa in iron-replete patients with CAA might be improved with concomitant administration of IV iron.,This study investigated response darbepoetin alfa iron-replete patients CAA improved concomitant administration IV iron.,G0000000|C0557651|C1292732|C0871261|G0000000|C0439095|C0302583|C0030705|G0000000|C0184511|C0521115|C0001554|C0022326|C0302583
"Additional analysis of this end point was undertaken via a repeated measures one-way analysis of variance (ANOVA) model, both as a confirmatory analysis and to allow for adjustment of the result in the presence of potential concomitant covariates, such as patient demographics and baseline Hb, baseline QOL, and other clinical variables.","Additional analysis undertaken repeated measures one-way analysis variance (ANOVA) model, confirmatory analysis adjustment result presence potential concomitant covariates, patient demographics baseline Hb, baseline QOL, clinical variables.",C1524062|C0002778|G0000000|C0205341|C0079809|C0205447|C0002778|C1711260|G0000000|C3161035|C0750484|C0002778|C0376209|C1274040|C0150312|C3245505|C0521115|G0000000|C0030705|C0011298|C0168634|C0019046|C0168634|C0518214|C0205210|C0439828
This study evaluated whether coadministration of parenteral iron improves ESA efficacy in patients with CAA.,This study evaluated coadministration parenteral iron improves ESA efficacy patients CAA.,G0000000|C0557651|C0220825|C0814472|C0030547|C0302583|C0184511|C3890206|C1280519|C0030705|G0000000
The study was not blinded because it was difficult for us to mask treatment; thiopental is liophylized for administration and pentobarbital is not.,The study blinded difficult mask treatment; thiopental liophylized administration pentobarbital not.,G0000000|C0557651|C0150108|C0332218|C0024861|C0039798|C0039925|G0000000|C0001554|C0030883|C1518422
"APACHE, Acute Physiology and Chronic Health Evaluation; admission CT, admission computed tomography (according to the Traumatic Coma Data Bank); ISS, Injury Severity Score; SAPS, Simplified Acute Physiology.","APACHE, Acute Physiology Chronic Health Evaluation; admission CT, admission computed tomography (according Traumatic Coma Data Bank); ISS, Injury Severity Score; SAPS, Simplified Acute Physiology.",C0243030|C0205178|C0031842|C0205191|C0018684|C0220825|C0184666|C0007673|C0184666|C1441526|C0040395|C0680240|C0332663|C0009421|C1511726|C0442598|C1845118|C3263722|C0439793|C0449820|C1705598|G0000000|C0205178|C0031842
Adherence with the patch protocol was assessed by having patients document their use of the patch and the number of cigarettes smoked that day on a daily calendar diary.,Adherence patch protocol assessed patients document patch cigarettes smoked day daily calendar diary.,C1510802|C0332461|C0442711|C1516048|C0030705|C1301746|C0332461|C0677453|C0037366|C0332173|C0332173|C1516147|C0376660
Until now no controlled studies have been reported that compare the effectiveness of pentobarbital and thiopental in controlling ICH.,Until controlled studies reported compare effectiveness pentobarbital thiopental controlling ICH.,G0000000|C2587213|C0947630|C0684224|C1707455|C1280519|C0030883|C0039925|C2239193|C0019191
"DA, darbepoetin alfa; IV, intravenous; pts, patients; Hb, hemoglobin.","DA, darbepoetin alfa; IV, intravenous; pts, patients; Hb, hemoglobin.",C0011318|G0000000|C0439095|C0022326|C0348016|C1419129|C0030705|C0019046|C0019046
"Even among patients with normal or increased total body iron stores, functional iron deficiency (ie, lack of bioavailable iron) as a result of inflammation-related hepcidin production and pathologic sequestration of iron in macrophages can restrict erythropoiesis and impair response to ESA treatment.","Even patients normal increased total body iron stores, functional iron deficiency (ie, lack bioavailable iron) result inflammation-related hepcidin production pathologic sequestration iron macrophages restrict erythropoiesis impair response ESA treatment.",G0000000|C0030705|C0205307|C0205217|C0439175|C0242821|C0302583|C1698986|C0205245|C0302583|C0011155|G0000000|C0332268|C0935763|C0302583|C1274040|C0021368|C0966897|C0033268|C1521733|C0443301|C0302583|C0024432|C0443288|C0014819|G0000000|C0871261|C3890206|C0039798
"To achieve this multivariate analysis, and given the small number of cases in each of the five groups in Marshall's classification, the CT data were grouped into focal and diffuse lesions.","To achieve multivariate analysis, Marshall's classification, CT data focal diffuse lesions.",C0040363|G0000000|G0000000|C0002778|C1551881|C0008902|C0007673|C1511726|C0205234|C0205219|C0221198
"Given that the randomization did not create groups that were similar in terms of types of intracranial lesions shown on the CT results, which is a prognostic variable that influences the effectiveness of barbiturate treatment in controlling ICP, we conducted a multivariate analysis using binary logistic regression, so that we would include the prognostic variables with the most plausible association with the dependent variable 'uncontrollable ICP'.","Given randomization create terms types intracranial lesions CT results, prognostic variable influences effectiveness barbiturate treatment controlling ICP, conducted multivariate analysis binary logistic regression, prognostic variables plausible association dependent variable 'uncontrollable ICP'.",C1442162|C0034656|C1706214|C0233324|C0332307|C0524466|C0221198|C0007673|C1274040|C0220901|C0439828|C4054723|C1280519|C0004745|C0039798|C2239193|C1881201|C0004927|G0000000|C0002778|C1706942|C0242415|C0684320|C0220901|C0439828|G0000000|C0004083|C0851827|C0439828|G0000000|C1881201
"All data collection, counseling, education, support, and brief follow-up counseling were performed by four trained research assistants who ranged in level of education from an undergraduate student to a research assistant who had a master's degree.","All data collection, counseling, education, support, follow-up counseling performed trained assistants ranged level education undergraduate student assistant master's degree.",G0000000|C1511726|C1516698|C0010210|C0013621|C0183683|C0589120|C0010210|C0884358|C0336809|C0011327|C1514721|C0441889|C0013621|C0682177|C0038492|C0011327|C0444649|C0441889
"To determine whether variables followed a normal distribution, we used the Shapiro Wilks test.","To determine variables normal distribution, Shapiro Wilks test.",C0040363|G0000000|C0439828|C0205307|C0520511|G0000000|G0000000|C0022885
All treatment comparisons were made in a pairwise fashion by using oral placebo treatment as a reference.,All treatment comparisons pairwise fashion oral placebo treatment reference.,G0000000|C0039798|C1707455|G0000000|G0000000|C0442027|C0032042|C0039798|C1514811
"In addition, we required a CT to have been conducted within 24 hours before inclusion of the patient in the study; intravenous administration of 0.7 g/kg mannitol 1 hour before randomization; or a plasmatic osmolarity measurement above 320 mOsm/kg, in order to ensure that hyperosmolar therapy had been optimized before inclusion.","In addition, required CT conducted 24 hours inclusion patient study; intravenous administration 0.7 g/kg mannitol 1 hour randomization; plasmatic osmolarity measurement 320 mOsm/kg, ensure hyperosmolar therapy optimized inclusion.",G0000000|C0332287|C1514873|C0007673|C0004927|C0450371|C0439227|C0007637|C0030705|C0557651|C0348016|C0001554|G0000000|C1300563|C0024730|G0000000|C0439227|C0034656|C0032105|C0029387|C0242485|C1442061|C0439353|C0218063|C0259752|C0039798|G0000000|C0007637
Kruskal-Wallis and one-way ANOVA procedures were used to make comparisons across the three treatment arms on secondary continuous variates.,Kruskal-Wallis one-way ANOVA procedures comparisons treatment arms secondary continuous variates.,G0000000|C0205447|G0000000|C0025664|C1707455|C0039798|C0206655|C0027627|C0549178|G0000000
"At 6 months, quit rates were 17.1% (35/205) with the nicotine patch, a。，nd 11.7% (24/205) with the placebo patch (p=.08).","At 6 months, quit rates 17.1% (35/205) nicotine patch, a。，nd 11.7% (24/205) placebo patch (p=.08).",G0000000|G0000000|C0439231|C0748223|C0871208|C0450371|C0450371|C0028040|C0332461|G0000000|C0450371|C0450371|C0032042|C0332461|C0369773
"In patients with ICP greater than 20 mmHg, initial treatment included elevation of the head of the bed, keeping the neck straight, appropriate sedation, muscular paralysis, ventricular drainage (if the patient had visible ventricles on the CT), 20% mannitol (0.25 to 0.75 mg/kg), 7.5% hypertonic saline (2 ml/kg) and moderate hyperventilation (partial carbon dioxide tension of 30 to 35 mmHg).","In patients ICP 20 mmHg, initial treatment included elevation head bed, keeping neck straight, sedation, muscular paralysis, ventricular drainage (if patient visible ventricles CT), 20% mannitol (0.25 0.75 mg/kg), 7.5% hypertonic saline (2 ml/kg) moderate hyperventilation (partial carbon dioxide tension 30 35 mmHg).",G0000000|C0030705|C1881201|C0450371|C0439475|C0205265|C0039798|C0332257|C0439775|C0018670|C0004916|C0333118|C0027530|C0445291|C0235195|C0026845|C0522224|C0018827|C0012621|G0000000|C0030705|C0205379|C0007799|C0007673|C0450371|C0024730|C0450371|C0450371|C0439272|G0000000|G0000000|C0036082|G0000000|C1300574|C0205081|C0020578|C0728938|C0007009|C0678717|C0233494|C0450371|C0450371|C0439475
"The study was conducted by the Mayo Clinic Cancer Research Consortium (MCCRC), an organization with similar membership to the North Central Cancer Treatment Group (NCCTG) but without National Cancer Institute (NCI) financial or administrative support.","The study conducted Mayo Clinic Cancer Research Consortium (MCCRC), organization membership North Central Cancer Treatment Group (NCCTG) National Cancer Institute (NCI) financial administrative support.",G0000000|C0557651|C0004927|C0454788|C0002424|C0006826|C0035168|C1513822|G0000000|C0029237|C0680038|C1709269|C0205099|C0006826|C0039798|C0441833|C1518419|C3245503|C0006826|C0021622|C1513882|C0376243|C1292785|C0183683
"When compared with whites, African Americans smoke fewer cigarettes,8 and are less likely to be heavy smokers and more likely to smoke mentholated and higher tar and nicotine brands.9 Although African Americans are more likely than white smokers to have quit for at least 1 day during the previous year,10 and to be confident that they will be abstinent at 1 year,11 African Americans who attempt to quit are significantly less likely than whites to remain abstinent for 1 year or more, even after adjustment for socioeconomic factors.10, 12 In U.S. smokers, without any smoking cessation intervention, the annual spontaneous quit rates range from 2% to 5%.13, 14 Quit rates can be significantly improved with the nicotine transdermal patch, which has been studied extensively in smoking cessation trials largely composed of white, middle-class smokers.","When compared whites, African Americans smoke fewer cigarettes,8 heavy smokers smoke mentholated tar nicotine brands.9 Although African Americans white smokers quit 1 day previous year,10 confident abstinent 1 year,11 African Americans attempt quit whites remain abstinent 1 more, adjustment socioeconomic factors.10, 12 In U.S. smokers, smoking cessation intervention, annual spontaneous quit rates range 2% 5%.13, 14 Quit rates improved nicotine transdermal patch, studied extensively smoking cessation trials composed white, middle-class smokers.",G0000000|C1707455|C0007457|C0027567|C0596070|C0037366|C0205388|C0677453|C0439539|C0337664|C0037366|C0025368|C0039315|C0028040|C0592503|G0000000|C0027567|C0596070|C0007457|C0337664|C0748223|G0000000|C0332173|C0205156|C0439234|C0205423|C0457801|G0000000|C0439234|C0027567|C0596070|C1516084|C0748223|C0007457|G0000000|C0457801|G0000000|C0205172|C0376209|C0748878|C1521761|C0450371|G0000000|C0041703|C0337664|C0037369|C1880019|C0886296|C0332181|C0205359|C0748223|C0871208|C1514721|G0000000|C0450371|C0450371|C0748223|C0871208|C0184511|C0028040|C0040652|C0332461|C0557651|G0000000|C0037369|C1880019|C0008976|G0000000|C0007457|C0682201|C0337664
A computer-generated random numbers table with a block size set at 20 was used to randomize 410 patients to one of two study arms.,A computer-generated random table block size set 20 randomize 410 patients study arms.,G0000000|C0009622|C0034656|C0039224|C0028778|C0456389|C0036849|C0450371|G0000000|C1442061|C0030705|C0557651|C0206655
"The general treatment objectives in patients with severe TBI were to maintain MAP above 80 mmHg, ICP below 20 mmHg, and cerebral perfusion pressure above 60 mmHg.","The treatment objectives patients severe TBI maintain MAP 80 mmHg, ICP 20 mmHg, cerebral perfusion pressure 60 mmHg.",G0000000|C0039798|C0018017|C0030705|C0205082|C0876926|C0024501|C0024779|C0450371|C0439475|C1881201|C0450371|C0439475|G0000000|C0031001|C0033095|C0450371|C0439475
"In other cases, we used the Mann-Whitney U-test.","In cases, Mann-Whitney U-test.",G0000000|C0868928|G0000000|C0022885
"CT, computed tomography; GCS, Glasgow Coma Scale.","CT, computed tomography; GCS, Glasgow Coma Scale.",C0007673|C1441526|C0040395|G0000000|G0000000|C0009421|C0175659
"Multimodal program involving exercise, nutritional, and psychological interventions initiated before (Prehab group) or after (Rehab group) surgery.","Multimodal program involving exercise, nutritional, psychological interventions initiated (Prehab group) (Rehab group) surgery.",C1513743|C1709697|C1314939|C0015259|C1521739|C0205486|C0886296|C1548602|G0000000|C0441833|C0034991|C0441833|C0038894
"The systemic monitoring of these patients included invasive blood pressure, pulse oximetry, and a pulmonary artery thermodilution catheter.","The systemic monitoring patients included invasive blood pressure, pulse oximetry, pulmonary artery thermodilution catheter.",G0000000|C0205373|C0150369|C0030705|C0332257|C0205281|C0005767|C0033095|C0232117|C0523807|C0024109|C0003842|C0039807|C0085590
Smoking cessation was defined as self-reported abstinence (not even a puff) since the last visit.,Smoking cessation defined self-reported abstinence (not puff) visit.,C0037369|C1880019|C1704788|C0681906|C3843422|C1518422|C1533107|C0545082
"Treatment with erythropoiesis-stimulating agents (ESAs) results in improved hemoglobin (Hb) levels in 40% to 70% of patients with CAA, and ESAs also decrease transfusion requirements.","Treatment erythropoiesis-stimulating agents (ESAs) improved hemoglobin (Hb) levels 40% 70% patients CAA, ESAs decrease transfusion requirements.",C0039798|C0014819|C0450442|C3472649|C0184511|C0019046|C0019046|C0441889|C0450371|C0450371|C0030705|G0000000|C3472649|C0392756|C0005841|C1514873
Additional details of the random assignment process are provided in the Appendix (online only).,Additional details random assignment process provided Appendix (online only).,C1524062|C1522508|C0034656|C1516050|C1184743|C1999230|C0003617|G0000000|C0205171
CONSORT diagram.,CONSORT diagram.,G0000000|C0681494
High dosages of barbiturates are used in patients with severe traumatic brain injury (TBI) who present with refractory intracranial hypertension (ICH) after medical and surgical treatment.,High dosages barbiturates patients severe traumatic brain injury (TBI) refractory intracranial hypertension (ICH) medical surgical treatment.,C0205250|C0178602|C0004745|C0030705|C0205082|C0332663|C0006104|C3263722|C0876926|C0205269|C0524466|C0020538|C0019191|C0199168|C0543467|C0039798
Active recruitment was conducted from the nonappointment medical walk-in clinic and the lobby of the clinic building between the hours of 8 amand 5 pmon weekdays.,Active recruitment conducted nonappointment medical walk-in clinic lobby clinic building hours 8 amand 5 pmon weekdays.,C0205177|C2949735|C0004927|G0000000|C0199168|C3846681|C0002424|C0023927|C0002424|C1547706|C0439227|G0000000|G0000000|G0000000|G0000000|C0680189
"To be enrolled in the study, patients were then scheduled for their randomization visit and quit date.","To enrolled study, patients scheduled randomization visit quit date.",C0040363|G0000000|C0557651|C0030705|C0086960|C0034656|C0545082|C0748223|C0011008
"Tobacco use is the major contributor to cardiovascular disease, cancer, and cerebrovascular disease, the three leading causes of death in the United States.1 In 1993, approximately 46 million U.S. adults smoked,2 of whom more than 6 million were African American.3 Over the past three decades, smoking prevalence rates for African Americans and whites have both declined, from 46% to 26% for African Americans, and from 42% to 25% for whites.4 However, prevalence rates for inner-city African Americans remain high, ranging from 33% to 54%.5 6,5–7 In Harlem, prevalence rates reported for African–American men have been as high as 60% in health care settings and 52% in housing developments.7 Despite such high smoking rates among inner-city African Americans, research in smoking cessation has been conducted almost exclusively in white, middle-class populations.","Tobacco major contributor cardiovascular disease, cancer, cerebrovascular disease, leading death United States.1 In 1993, 46 U.S. adults smoked,2 6 African American.3 Over decades, smoking prevalence rates African Americans whites declined, 46% 26% African Americans, 42% 25% whites.4 However, prevalence rates inner-city African Americans remain high, ranging 33% 54%.5 6,5–7 In Harlem, prevalence rates reported African–American 60% health care settings 52% housing developments.7 Despite smoking rates inner-city African Americans, smoking cessation conducted exclusively white, middle-class populations.",C0040329|C0205082|G0000000|C0007226|C0012634|C0006826|C1880018|C0012634|C0332152|C0011065|C0166872|C1301808|G0000000|G0000000|C0450371|C0041703|C0001675|C0037366|G0000000|C0027567|C0596070|C0205136|C2981279|C0037369|C0033105|C0871208|C0027567|C0596070|C0007457|G0000000|C0450371|C0450371|C0027567|C0596070|C0450371|C0450371|C0007457|G0000000|C0033105|C0871208|C0557849|C0027567|C0596070|G0000000|C0205250|C1514721|C0450371|C0450371|G0000000|G0000000|G0000000|C0033105|C0871208|C0684224|G0000000|C0450371|C0018684|C1947933|C0542559|C0450371|C0020056|C0243107|G0000000|C0037369|C0871208|C0557849|C0027567|C0596070|C0037369|C1880019|C0004927|G0000000|C0007457|C0682201|C0032659
"Refractory ICH was defined as follows: ICP 21 to 29 mmHg for 30 minutes or more, ICP of 30 to 39 mmHg for 15 minutes or more, or ICP greater than 40 mmHg for more than 1 minute, in the absence of external interventions.","Refractory ICH defined follows: ICP 21 29 mmHg 30 minutes more, ICP 30 39 mmHg 15 minutes more, ICP 40 mmHg 1 minute, absence external interventions.",C0205269|C0019191|C1704788|C0332283|C1881201|C0450371|C0450371|C0439475|C0450371|C0439232|C0205172|C1881201|C0450371|C0450371|C0439475|C0450371|C0439232|C0205172|C1881201|C0450371|C0439475|G0000000|C0439232|C0332197|C0205101|C0886296
"This practice is recommended in the Brain Trauma Foundation (BTF) Guidelines, because this is the only second-level measure for which there is class II evidence that it can reduce intracranial pressure (ICP) [1].","This practice recommended Brain Trauma Foundation (BTF) Guidelines, second-level measure class II evidence reduce intracranial pressure (ICP) [1].",G0000000|C0237607|C0034866|C0006104|C0043251|C0016617|C1424602|C0162791|C0563054|C0079809|C0456387|G0000000|C3887511|G0000000|C0524466|C0033095|C1881201|G0000000
The study was concluded prematurely because of the unexpected and slow inclusion rate; this could have modified some uncontrollable environmental factors that may affect results.,The study concluded prematurely unexpected slow inclusion rate; modified uncontrollable environmental factors affect results.,G0000000|C0557651|C0917903|G0000000|C4055646|C0439834|C0007637|C0871208|C0392747|G0000000|C0014406|C1521761|C0001721|C1274040
"The patch has been found to be both clinically effective,5,15–17 and cost-effective,14, 18 and has been recommended by the Agency for the Health Care Policy and Research Smoking Cessation Clinical Practice Guidelines.19 Owing to the lack of information on the nicotine patch in assisting African–American smokers to quit, we conducted a double-blind, placebo-controlled, randomized trial to evaluate its efficacy as an adjunct to brief counseling and education, in an inner-city population.","The patch clinically effective,5,15–17 cost-effective,14, 18 recommended Agency Health Care Policy Research Smoking Cessation Clinical Practice Guidelines.19 Owing lack nicotine patch assisting African–American smokers quit, conducted double-blind, placebo-controlled, randomized trial evaluate efficacy adjunct counseling education, inner-city population.",G0000000|C0332461|G0000000|G0000000|C0010181|C0450371|C0034866|C0237463|C0018684|C1947933|C0242456|C0035168|C0037369|C1880019|C0205210|C0237607|C0162791|G0000000|C0332268|C0028040|C0332461|C0557034|G0000000|C0337664|C0748223|C0004927|C0013072|C1706408|C0034656|C0008976|C0220825|C1280519|G0000000|C0010210|C0013621|C0557849|C0032659
Both study staff and patients were blinded to patch treatment.,Both study staff patients blinded patch treatment.,G0000000|C0557651|C0851286|C0030705|C0150108|C0332461|C0039798
"For the comparison of quantitative variables, Student's t-test was used if the variable followed a normal distribution.","For comparison quantitative variables, Student's t-test variable normal distribution.",G0000000|C1707455|C0392762|C0439828|C0038492|C0871472|C0439828|C0205307|C0520511
"Secondary objectives were to compare the incidence of secondary effects, especially arterial hypotension, which was defined as the presence of mean arterial pressure (MAP) under 80 mmHg at any point during barbiturate therapy.","Secondary objectives compare incidence secondary effects, arterial hypotension, defined presence arterial pressure (MAP) 80 mmHg barbiturate therapy.",C0027627|C0018017|C1707455|C0021149|C0027627|C1280500|C0003842|C0020649|C1704788|C0150312|C0003842|C0033095|C0024779|C0450371|C0439475|C0004745|C0039798
"Accepting an α error of 0.05 and a β error of 0.2 in a bilateral hypothesis contrast, we estimated that 47 patients were needed in each group to detect differences of 30% or greater in the control of ICH.","Accepting α error 0.05 β error 0.2 bilateral hypothesis contrast, estimated 47 patients detect differences 30% control ICH.",C1272684|G0000000|C0743559|C0450371|G0000000|C0743559|G0000000|C0238767|C1512571|C0009924|C0750572|C0450371|C0030705|C0442726|C1705241|C0450371|C0243148|C0019191
"In all cases, the patient's closest relative, legal representative, or guardian gave written informed consent for their inclusion in the study.","In cases, patient's closest relative, legal representative, guardian written informed consent inclusion study.",G0000000|C0868928|C0030705|C1522666|C0080103|C1301860|C1882932|C0023226|C0043266|C1522154|C1511481|C0007637|C0557651
"Quantitative variables are expressed as the mean and standard deviation from the mean (SD) in normal distributions, and as median and interquartile range in cases that were not normally distributed.","Quantitative variables expressed standard deviation (SD) normal distributions, median interquartile range distributed.",C0392762|C0439828|G0000000|C1442989|C0012727|G0000000|C0205307|C0037775|C0549183|G0000000|C1514721|C1704711
Baseline characteristics were comparable between randomly assigned groups (Table 1).,Baseline characteristics comparable randomly assigned (Table 1).,C0168634|C1521970|G0000000|G0000000|C1516050|C0039224|G0000000
"At this visit, patients received their initial 2 weeks of 21 mg/d patches, and had a 1-hour visit with a counselor for instructions on the use of the patch, brief education about the risks of smoking and the benefits of quitting, and general medical advice.","At visit, patients received initial 2 weeks 21 mg/d patches, 1-hour visit counselor instructions patch, education risks smoking benefits quitting, medical advice.",G0000000|C0545082|C0030705|C1514756|C0205265|G0000000|C0439230|C0450371|C0439422|C0994894|C0439227|C0545082|C1561602|C0302828|C0332461|C0013621|C0035647|C0037369|C0814225|C0748223|C0199168|C0150600
All of these guidelines also state that more research is needed regarding optimal iron dose and schedule and selection of suitable patients.,All guidelines optimal iron dose schedule selection suitable patients.,G0000000|C0162791|C2698651|C0302583|C0178602|C0086960|C0036576|C3900053|C0030705
"To achieve these objectives, we used liquids and/or vasoactive support with norepinephrine (noradrenaline).","To achieve objectives, liquids and/or vasoactive support norepinephrine (noradrenaline).",C0040363|G0000000|C0018017|C0302908|G0000000|C1980011|C0183683|C0028351|C0028351
"Patients were recruited by self-referral, referral by physicians, or active recruitment.","Patients recruited self-referral, referral physicians, active recruitment.",C0030705|G0000000|C0237824|C0034927|C0031831|C0205177|C2949735
The study was registered at http://www.clinicaltrials.gov.,The study registered http://www.clinicaltrials.gov.,G0000000|C0557651|C1514821|C1555015
aPupillary reactivity at hospital admission.,aPupillary reactivity hospital admission.,G0000000|C0443286|C0019994|C0184666
Data collection and patient follow up were conducted by the same investigator (JPB).,Data collection patient follow conducted investigator (JPB).,C1511726|C1516698|C0030705|C0332283|C0004927|C0035173|G0000000
Patients who relapsed to smoking cigarettes were advised to discontinue using the patch and set another quit date.,Patients relapsed smoking cigarettes advised discontinue patch set quit date.,C0030705|C0205336|C0037369|C0677453|G0000000|C1444662|C0332461|C0036849|C0748223|C0011008
This 8 1/2-by-11-inch manual is printed on glossy paper and includes a number of color photographs and line drawings.,This 8 1/2-by-11-inch manual printed glossy paper includes color photographs drawings.,G0000000|G0000000|C0450371|C0024763|C0033161|G0000000|C0030351|C0332257|C0009393|C0441468|C0013113
"Several clinical practice guidelines—including those from the American Society of Hematology/American Society of Clinical Oncology, the National Comprehensive Cancer Network (http://www.nccn.org), and the European Organisation for Research and Treatment of Cancer—now recommend consideration of iron supplementation, including parenteral iron, for patients with CAA receiving ESAs.","Several clinical practice guidelines—including American Society Hematology/American Society Clinical Oncology, National Comprehensive Cancer Network (http://www.nccn.org), European Organisation Research Treatment Cancer—now recommend consideration iron supplementation, including parenteral iron, patients CAA receiving ESAs.",C0439064|C0205210|C0237607|G0000000|C0596070|C0037455|C0018943|C0037455|C0205210|C0027651|C3245503|C1880156|C0006826|C0150775|C1555015|C0239307|C0029237|C0035168|C0039798|G0000000|C0034866|C0518609|C0302583|C0242297|C0332257|C0030547|C0302583|C0030705|G0000000|C1514756|C3472649
"To calculate sample size, we assumed that the therapeutic response rate in the pentobarbital group would be 50%, excluding patients lost to follow up.","To calculate sample size, assumed therapeutic response rate pentobarbital 50%, excluding patients lost follow up.",C0040363|C1441506|C0370003|C0456389|C3242379|C0087111|C0871261|C0871208|C0030883|C0450371|C0332196|C0030705|C0745777|C0332283|G0000000
"To analyze the variable ICP, which was determined on an hourly basis, we calculated the area under the curve (AUC) at 24, 48 and 72 hours, and also standardized by time [15].","To analyze variable ICP, determined hourly basis, calculated curve (AUC) 24, 48 72 hours, standardized time [15].",C0040363|G0000000|C0439828|C1881201|G0000000|C0558292|C1527178|C0444686|C0205134|C0376690|C0450371|C0450371|C0450371|C0439227|G0000000|C0040223|C0450371
"The study design was a double-blind, placebo-controlled, randomized trial of 10 weeks of patches.","The study design double-blind, placebo-controlled, randomized trial 10 weeks patches.",G0000000|C0557651|C1707689|C0013072|C1706408|C0034656|C0008976|C0450371|C0439230|C0994894
"The pretreatment transferrin saturation (TfSat) level was similar among Hb responders and nonresponders (mean TfSat, 21.7% for responders v 21.0% for nonresponders; P = .60); there were also no differences in baseline TfSat values in the responders versus nonresponders in any individual arm.","The pretreatment transferrin saturation (TfSat) level Hb responders nonresponders (mean TfSat, 21.7% responders 21.0% nonresponders; P = .60); differences baseline TfSat values responders versus nonresponders individual arm.",G0000000|C1550147|C0040679|C0522534|G0000000|C0441889|C0019046|G0000000|G0000000|C0444504|G0000000|C0450371|G0000000|C0450371|G0000000|C0369773|G0000000|C0450371|C1705241|C0168634|G0000000|C0042295|G0000000|G0000000|G0000000|C0027361|C0446516
"Since 2004, five published randomized studies have reported a variety of benefits with IV iron use compared with oral iron or no iron in ESA-treated patients with CAA.","Since 2004, published randomized studies reported variety benefits IV iron compared oral iron iron ESA-treated patients CAA.",C1711239|G0000000|C0034037|C0034656|C0947630|C0684224|C1883525|C0814225|C0022326|C0302583|C1707455|C0442027|C0302583|C0302583|C3890206|C0030705|G0000000
"Statistical analyses were conducted using SPSS version 15 (SPSS Inc., Chicago, IL, USA).","Statistical analyses conducted SPSS version 15 (SPSS Inc., Chicago, IL, USA).",C0038215|C0002778|C0004927|C3813609|C0333052|C0450371|C3813609|G0000000|C0008044|C0020898|C0041703
"Of the remaining 1510 eligible women, 1444 (96%) received both exams and comprise the analysis set.","Of remaining 1510 eligible women, 1444 (96%) received exams comprise analysis set.",G0000000|C1527428|G0000000|C1548635|C0043210|G0000000|C0450371|C1514756|C0582103|C2700400|C0002778|C0036849
"The study began in November 1993, and all 6-month follow-up visits were completed by March 1995.","The study November 1993, 6-month follow-up visits completed March 1995.",G0000000|C0557651|C3828767|G0000000|C0332177|C0589120|C0545082|C0205197|C3829202|G0000000
The CT findings on inclusion were regarded to be the worst of the hospital stay; the prognostic value of such CT findings have been described by other authors [9].,The CT findings inclusion regarded worst hospital stay; prognostic CT findings authors [9].,G0000000|C0007673|C2607943|C0007637|G0000000|C1522166|C0019994|G0000000|C0220901|C0007673|C2607943|C3812881|G0000000
"Based on various studies conducted in laboratory animals [3-6], suggesting that the neuroprotective capacity of thiopental is superior, our working hypothesis was that thiopental is more effective than pentobarbital in controlling ICP in patients with severe TBI, with a similar incidence of adverse side effects.","Based studies conducted laboratory animals [3-6], suggesting neuroprotective capacity thiopental superior, hypothesis thiopental effective pentobarbital controlling ICP patients severe TBI, incidence adverse effects.",C1527178|C0947630|C0004927|C0022877|C0003062|G0000000|C1705535|C0598958|C1516240|C0039925|C1282910|C1512571|C0039925|C1280519|C0030883|C2239193|C1881201|C0030705|C0205082|C0876926|C0021149|G0000000|C1280500
The safety population also included all patients who received one or more darbepoetin dose.,The safety population included patients received darbepoetin dose.,G0000000|C0036043|C0032659|C0332257|C0030705|C1514756|G0000000|C0178602
"The significant variables identified by the 'likelihood ratio' ≤ 0.1 test were used, along with those whose inclusion affected the calculation of the effect of the 'treatment group' variable.","The variables identified 'likelihood ratio' ≤ 0.1 test used, inclusion calculation 'treatment group' variable.",G0000000|C0439828|C0205396|C0033204|C0456603|G0000000|G0000000|C0022885|C1273517|C0007637|C1441506|C0039798|C0441833|C0439828
Vertical lines represent error bars.,Vertical lines represent error bars.,C0205128|C0205132|C1882932|C0743559|C1707156
"Patients also received an instructional 34-minute audiocassette titled “Nicoderm: Behavioral Support and Proper Use Information.” The audiocassette covers issues surrounding nicotine patch use for 8 minutes, and for the remaining 26 minutes it covers coping techniques, relaxation techniques, and behavioral change issues.","Patients received instructional 34-minute audiocassette titled “Nicoderm: Behavioral Support Proper Use Information.” The audiocassette covers issues surrounding nicotine patch 8 minutes, remaining 26 minutes covers coping techniques, relaxation techniques, behavioral change issues.",C0030705|C1514756|C0039401|C0450371|C0681507|C1519530|G0000000|C0004927|C0183683|G0000000|C0042153|G0000000|G0000000|C0681507|C0180153|C0033213|C1282914|C0028040|C0332461|G0000000|C0439232|C1527428|C0450371|C0439232|C0180153|C0009967|C0025664|C0035028|C0025664|C0004927|C0392747|C0033213
Efficacy data were analyzed for all patients who were randomly assigned and received at least one darbepoetin alfa dose.,Efficacy data analyzed patients randomly assigned received darbepoetin alfa dose.,C1280519|C1511726|C0936012|C0030705|G0000000|C1516050|C1514756|G0000000|C0439095|C0178602
"Under logistic regression analysis – undertaken in an effort to adjust for the cranial tomography characteristics, which were unfavourable for pentobarbital – thiopental was more effective than pentobarbital in terms of controlling intracranial pressure (odds ratio = 5.1, 95% confidence interval 1.2 to 21.9; P = 0.027).","Under logistic regression analysis – undertaken effort adjust cranial tomography characteristics, unfavourable pentobarbital – thiopental effective pentobarbital terms controlling intracranial pressure (odds ratio = 5.1, 95% confidence interval 1.2 21.9; P = 0.027).",G0000000|C0242415|C0684320|C0002778|G0000000|G0000000|C0015264|G0000000|C0037303|C0040395|C1521970|C3640815|C0030883|G0000000|C0039925|C1280519|C0030883|C0233324|C2239193|C0524466|C0033095|G0000000|C0456603|G0000000|G0000000|C0450371|C0237529|C1272706|G0000000|C0450371|C0369773|G0000000|C1442061
To determine the efficacy of the transdermal nicotine patch for smoking cessation in inner-city African Americans.,To determine efficacy transdermal nicotine patch smoking cessation inner-city African Americans.,C0040363|G0000000|C1280519|C0040652|C0028040|C0332461|C0037369|C1880019|C0557849|C0027567|C0596070
Transfusions were administered at the discretion of investigators and were recommended for patients with Hb less than 8.0 g/dL or severe anemia-related symptoms.,Transfusions administered discretion investigators recommended patients Hb 8.0 g/dL severe anemia-related symptoms.,C0005841|C1521801|G0000000|C0035173|C0034866|C0030705|C0019046|G0000000|C0439267|C0205082|C0002871|C0683368
Functional iron deficiency may impair response to erythropoiesis-stimulating agents (ESAs) in iron-replete patients with chemotherapy-associated anemia (CAA).,Functional iron deficiency impair response erythropoiesis-stimulating agents (ESAs) iron-replete patients chemotherapy-associated anemia (CAA).,C0205245|C0302583|C0011155|G0000000|C0871261|C0014819|C0450442|C3472649|C0302583|C0030705|C0013216|C0002871|G0000000
"Double-blind, placebo-controlled, randomized trial.","Double-blind, placebo-controlled, randomized trial.",C0013072|C1706408|C0034656|C0008976
"In patients with CAA, addition of IV ferric gluconate to darbepoetin failed to provide additional benefit compared with oral iron or oral placebo.","In patients CAA, addition IV ferric gluconate darbepoetin failed provide additional benefit compared oral iron oral placebo.",G0000000|C0030705|G0000000|C0332287|C0022326|C2346593|C0017714|G0000000|C0231175|C1999230|C1524062|C0814225|C1707455|C0442027|C0302583|C0442027|C0032042
It has been hypothesized that intravenous (IV) iron administration might overcome functional iron deficiency by providing elemental iron in a readily bioavailable form to the developing erythron.,It hypothesized intravenous (IV) iron administration overcome functional iron deficiency providing elemental iron bioavailable form developing erythron.,G0000000|G0000000|C0348016|C0022326|C0302583|C0001554|C2983310|C0205245|C0302583|C0011155|C1999230|C0013879|C0302583|C0935763|C0348078|G0000000|G0000000
"Adequate response to treatment was defined as a decrease in ICP to below 20 mmHg, and maintenance below this threshold for at least 48 hours.","Adequate response treatment defined decrease ICP 20 mmHg, maintenance threshold 48 hours.",C0205410|C0871261|C0039798|C1704788|C0392756|C1881201|C0450371|C0439475|C0024501|C0449864|C0450371|C0439227
Included patients were required to be haemodynamically stable at the point of inclusion in the study; haemodynamic stability was defined as systolic blood pressure of 100 mmHg or greater.,Included patients required haemodynamically stable inclusion study; haemodynamic stability defined systolic blood pressure 100 mmHg greater.,C0332257|C0030705|C1514873|G0000000|C0205360|C0007637|C0557651|C0019010|C0205360|C1704788|C0039155|C0005767|C0033095|C1442061|C0439475|C1704243
"Quit rates at 10 weeks were 21.5% (44/205) with the nicotine patch, and 13.7% (28/205) with the placebo patch (p=.03).","Quit rates 10 weeks 21.5% (44/205) nicotine patch, 13.7% (28/205) placebo patch (p=.03).",C0748223|C0871208|C0450371|C0439230|C0450371|C0450371|C0028040|C0332461|C0450371|C0450371|C0032042|C0332461|C0369773
"Qualitative variables are expressed as percentages, along with 95% confidence interval (CI).","Qualitative variables expressed percentages, 95% confidence interval (CI).",C0205556|C0439828|G0000000|C0439165|C0450371|C0237529|C1272706|C0008107
Patients whose ICP remained high with conventional treatment were included in the study.,Patients ICP remained conventional treatment included study.,C0030705|C1881201|G0000000|C0439858|C0039798|C0332257|C0557651
"There were no statistically significant differences with respect to epidemiological data, co-morbidity (data not shown) or lesions associated with TBI, although there were differences in the CT classification.","There statistically differences respect epidemiological data, co-morbidity (data shown) lesions TBI, differences CT classification.",G0000000|C0038215|C1705241|C0679133|C0014507|C1511726|C0009488|C1511726|C1547282|C0221198|C0876926|C1705241|C0007673|C0008902
"The ICP, MAP and cerebral perfusion pressure data were gathered on an hourly basis (one value every full hour) throughout the study using the Care Vue® clinical monitoring system (Phillips, Eindhoven, The Netherlands).","The ICP, MAP cerebral perfusion pressure data gathered hourly basis (one hour) study Care Vue® clinical monitoring system (Phillips, Eindhoven, The Netherlands).",G0000000|C1881201|C0024779|G0000000|C0031001|C0033095|C1511726|G0000000|C0558292|C1527178|C0205447|C0439227|C0557651|C1947933|G0000000|C0205210|C0150369|C0449913|G0000000|G0000000|G0000000|C0027778
"After adjusting for baseline differences in age and educational attainment, differences remained significant at 10 weeks (p=.04), but were not significant at 6 months (p=.14).","After adjusting baseline differences age educational attainment, differences remained 10 weeks (p=.04), 6 months (p=.14).",G0000000|G0000000|C0168634|C1705241|C0001779|C0587721|G0000000|C1705241|G0000000|C0450371|C0439230|C0369773|G0000000|C0439231|C0369773
Neurosurgical interventions were undertaken when necessary to evacuate surgical lesions.,Neurosurgical interventions undertaken evacuate surgical lesions.,G0000000|C0886296|G0000000|G0000000|C0543467|C0221198
"Random assignment was stratified by patient sex, tumor type (solid tumors v hematologic malignancies), severity of anemia on the basis of the WHO classification (mild, Hb ≥ 9.5 g/dL; severe, Hb < 9.5 g/dL), and whether or not patients were receiving a platinum-containing chemotherapy regimen.","Random assignment stratified patient sex, tumor type (solid tumors hematologic malignancies), severity anemia basis WHO classification (mild, Hb ≥ 9.5 g/dL; severe, Hb < 9.5 g/dL), patients receiving platinum-containing chemotherapy regimen.",C0034656|C1516050|C0205363|C0030705|C0009253|C0027651|C0332307|C0205208|C0027651|C0018943|C0006826|C0439793|C0002871|C1527178|G0000000|C0008902|C2945599|C0019046|G0000000|G0000000|C0439267|C0205082|C0019046|G0000000|G0000000|C0439267|C0030705|C1514756|C0032207|C0013216|C0040808
"The study protocol was approved by the Emory University School of Medicine Human Investigations Committee, and all study subjects gave written informed consent at the screening visit after the nature of the study had been fully explained.","The study protocol approved Emory University School Medicine Human Investigations Committee, study subjects written informed consent screening visit nature study explained.",G0000000|C0557651|C0442711|C0205540|G0000000|C0041740|C0036375|C0013227|C0086418|C1261322|C2699414|C0557651|C0681850|C0043266|C1522154|C1511481|C0220908|C0545082|C0349590|C0557651|G0000000
"Three ICP blocks were considered for further analysis: less than 20 mmHg, 20 to 30 mmHg, and more than 30 mmHg.","Three ICP blocks considered analysis: 20 mmHg, 20 30 mmHg, 30 mmHg.",C0205449|C1881201|C0028778|C0750591|C0002778|C0450371|C0439475|C0450371|C0450371|C0439475|C0450371|C0439475
"We also defined as unresponsive to treatment those cases in which, because of refractory ICP, the patient needed some other treatment (surgery and/or lumbar drainage) and cases in which the patient progressed to brain death.","We defined unresponsive treatment which, refractory ICP, patient treatment (surgery and/or lumbar drainage) patient progressed brain death.",G0000000|C1704788|C0205269|C0039798|G0000000|C0205269|C1881201|C0030705|C0039798|C0038894|G0000000|C0024090|C0012621|C0030705|C1272688|C0006104|C0011065
"For categoric variables, Fisher's exact tests were used for comparing binary secondary end points across the three treatments, such as RBC transfusion incidence rates.","For categoric variables, Fisher's exact tests comparing binary secondary treatments, RBC transfusion incidence rates.",G0000000|C0683312|C0439828|C0325045|C2828393|C0022885|C1707455|C1706942|C0027627|C0087111|C0014792|C0005841|C0021149|C0871208
